US oncology biotech Inspirna is winding down after a decade of operations, according to a LinkedIn post from chief executive Usman Azam. He said the New York-based company would close after “ten ...
The biotech, which has raised more than $140 million over several investment rounds in the last few years from the likes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback